Blood Glucose and HbA1c. Elevated blood glucose level
Conditions
Interventions
Intervention 1: Intervention group: The intervention group receives a training package based on cognitive-behavioral program (CBP) in the form of an interactive training application in the CBP method
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Ages 30 to 60 years BMI<35 No history of diabetes or cardiovascular disease No pregnancy or breastfeeding Ability to do physical activity (walking) Ability to speak Persian Do not suffer from severe mental illness Do not have cognitive disorders such as dementia and Alzheimer's Do not take anti-diabetic and anti-obesity drugs Willingness to participate in the study Waist circumference equal to or greater than 102 cm for men and 88 cm for women Blood sugar equal to or greater than 100 mg / dL Systolic blood pressure greater than or equal to 130 and diastolic blood pressure greater than or equal to 85 mm Hg Have three of the 5 American Heart Association criteria for Metabolic Syndrome,
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alteration in HbA1C level in during one-year follow-up. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed.(High-performance liquid chromatography).;Fasting plasma glucose in during one-year follow-up. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed.(With the autoanalyzer approach and with Pars test kits). | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol level,. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed(With the autoanalyzer approach and with Pars test kits).;Triglyceride level. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed(With the autoanalyzer approach and with Pars test kits).;Low Density Lipoprotein level. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed(With the autoanalyzer approach and with Pars test kits).;High Density Lipoprotein level. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed (With the autoanalyzer approach and with Pars test kits).;Change in waist circumference. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed(Waist circumference is measured according to the standard protocol (NHENSE). ).;Change in body mass index. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed(Body mass index will be obtained by dividing weight (kg) by height squared (square meters)).;Changes in blood pressure levels. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed(Blood pressure is measured according to the JNC8 protocol, blood pressure is measured twice at an interval of 30 minutes and the average of these two pressures is recorded as a person's blood pressure. ).;Changing eating habits. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Completing the questionnaire the Adolescent Food Habit checklist.;Physical activity. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Completing the questionnaire INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE(IPAQ).;Quit Smoking. Timepoint: At onset and 6 and 12 mont | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Bahramnezhad
Tehran University of Medical Sciences
Outcome results
None listed